PL368946A1 - Synergiczne połączenie ligandów receptora wiążącego retynoidy i wybranych środków cytotoksycznych do leczenia raka - Google Patents

Synergiczne połączenie ligandów receptora wiążącego retynoidy i wybranych środków cytotoksycznych do leczenia raka

Info

Publication number
PL368946A1
PL368946A1 PL02368946A PL36894602A PL368946A1 PL 368946 A1 PL368946 A1 PL 368946A1 PL 02368946 A PL02368946 A PL 02368946A PL 36894602 A PL36894602 A PL 36894602A PL 368946 A1 PL368946 A1 PL 368946A1
Authority
PL
Poland
Prior art keywords
cancer
treatment
cytotoxic agents
receptor ligands
binding receptor
Prior art date
Application number
PL02368946A
Other languages
English (en)
Inventor
Valerie Sandrine Vivat-Hannah
Matthew V. Lorenzi
Marco M. Gottardis
Fred Christopher Zusi
Original Assignee
Bristol-Myers Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol-Myers Squibb Company filed Critical Bristol-Myers Squibb Company
Publication of PL368946A1 publication Critical patent/PL368946A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL02368946A 2001-03-22 2002-03-22 Synergiczne połączenie ligandów receptora wiążącego retynoidy i wybranych środków cytotoksycznych do leczenia raka PL368946A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27775401P 2001-03-22 2001-03-22

Publications (1)

Publication Number Publication Date
PL368946A1 true PL368946A1 (pl) 2005-04-04

Family

ID=23062213

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02368946A PL368946A1 (pl) 2001-03-22 2002-03-22 Synergiczne połączenie ligandów receptora wiążącego retynoidy i wybranych środków cytotoksycznych do leczenia raka

Country Status (15)

Country Link
EP (1) EP1383491A2 (pl)
JP (1) JP2004528316A (pl)
KR (1) KR20030086314A (pl)
CN (1) CN1498105A (pl)
BR (1) BR0207681A (pl)
CA (1) CA2441335A1 (pl)
CZ (1) CZ20032540A3 (pl)
DE (1) DE02733871T1 (pl)
ES (1) ES2214985T1 (pl)
HU (1) HUP0400255A2 (pl)
IL (1) IL157358A0 (pl)
MX (1) MXPA03008403A (pl)
PL (1) PL368946A1 (pl)
TR (1) TR200400812T3 (pl)
WO (1) WO2002078620A2 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5113038B2 (ja) * 2006-03-23 2013-01-09 テムリック株式会社 癌治療用キットおよび癌治療用医薬組成物

Also Published As

Publication number Publication date
KR20030086314A (ko) 2003-11-07
JP2004528316A (ja) 2004-09-16
HUP0400255A2 (hu) 2004-08-30
TR200400812T3 (tr) 2004-07-21
EP1383491A2 (en) 2004-01-28
CN1498105A (zh) 2004-05-19
IL157358A0 (en) 2004-02-19
DE02733871T1 (de) 2004-08-26
CA2441335A1 (en) 2002-10-10
MXPA03008403A (es) 2004-01-29
BR0207681A (pt) 2004-07-27
ES2214985T1 (es) 2004-10-01
WO2002078620A2 (en) 2002-10-10
WO2002078620A3 (en) 2003-04-17
CZ20032540A3 (cs) 2004-05-12

Similar Documents

Publication Publication Date Title
PL370029A1 (pl) Pochodne 2-amino-4-heteroaryloaminopirymidyny do stosowania w leczeniu raka
ATE430570T1 (de) Synergistische kombinationstherapie zur krebsbehandlung
AU6147401A (en) Compositions and methods for the treatment of cancer
EP1296697A4 (en) Therapeutic agents - i
EP1355563A4 (en) METHODS OF PREVENTING AND TREATING CANCER WITH ANTI-C3B (I) ANTIBODIES
DE60014873D1 (de) Synergistische zusammensetzungen zur krebsbehandlung
GB0119152D0 (en) Therapeutic agents
DE60044507D1 (de) Flammhemmendes mischgewebe
NO20022692L (no) Terapeutiske midler
DK1176964T3 (da) Brug af ET743 til behandling af cancer
IL164896A (en) Pharmaceutical compositions comprising immunoconjugates for the treatment of tumors
IL161059A0 (en) Substituted benzimidazole compounds and their use for the treatment of cancer
EE200300366A (et) Meetodid nahahaiguste ravimiseks või tõkestamiseks CD2-siduvate vahendite abil
DE60223576D1 (de) Hautbehandlungszusammensetzung
MXPA03008582A (es) Agentes y metodos para tratamiento de cancer.
AU2001290165A8 (en) Components of canola for the treatment of cancer
GB0108930D0 (en) Therapeutic agents
GB0113839D0 (en) Therapeutic agents
EP1349485A4 (en) COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF OVARIAL CARCINOMA
PL368035A1 (pl) Kompozycje i sposoby leczenia raka
AU3483001A (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
GB0111191D0 (en) Therapeutic agents
IL160722A0 (en) Aryloxypropylamines as chemosensitizing agents in the treatment of cancer
EE200300057A (et) Koostis vähi profülaktikaks ja raviks
NO20016301D0 (no) Terapeutiske midler

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)